quinazolines has been researched along with sns 314 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, DA; Baskaran, S; Bui, M; Elling, RA; Flanagan, WM; Fung, AD; Hanan, EJ; Harris, S; Heumann, SA; Hoch, U; Jacobs, JW; Lam, J; Lawrence, CE; Lew, W; McDowell, RS; Nannini, MA; O'Brien, T; Oslob, JD; Romanowski, MJ; Shen, W; Silverman, JA; Sopko, MM; Tangonan, BT; Teague, J; Yoburn, JC; Yu, CH; Zhong, M; Zimmerman, KM | 1 |
| Klein, RQ; Lok, W; Saif, MW | 1 |
1 review(s) available for quinazolines and sns 314
| Article | Year |
|---|---|
Aurora kinase inhibitors as anti-cancer therapy.
Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Benzamides; Benzimidazoles; Cyclohexanecarboxylic Acids; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Neoplasms; Organophosphates; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Quinazolines; Thiazoles; Urea | 2010 |
1 other study(ies) available for quinazolines and sns 314
| Article | Year |
|---|---|
Discovery of a potent and selective aurora kinase inhibitor.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Structure-Activity Relationship; Thiazoles | 2008 |